Cite

HARVARD Citation

    Urabe, S. et al. (2015). Genetic Polymorphisms of IL-17F and TRAF3IP2 Could Be Predictive Factors of the Long-Term Effect of Infliximab against Crohn's Disease. BioMed research international. p. . [Online]. 
  
Back to record